A study of peripheral airway findings using an ultrathin bronchofiberscope and bronchoalveolar lavage fluid with diffuse panbronchiolitis

Respiration

Volumn 65, Issue 6, 1998, Pages 433-440

  Kikawada, Masayuki ^a   Ichinose, Yuichi ^a   Minemura, Kazushige ^a   Takasaki, Masaru ^a   Toyama, Keisuke ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Bronchoalveolar lavage fluid; Diffuse panbronchiolitis; Flow cytometry; Peripheral airway findings; Ultrathin bronchofiberscope

Indexed keywords

MACROLIDE;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; BRONCHIOLITIS; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; FEMALE; FIBEROPTIC BRONCHOSCOPY; HUMAN; LUNG LAVAGE; LYMPHOCYTE COUNT; MALE; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0031753608     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000029311     Document Type: Article

References (24)

1. Homma H, Yamanaka A, Tanimoto S, Tamura M, Chijimatsu Y, Kita S, Izumi T: Diffuse panbronchiolitis: A disease of the transitional zone of the lung. Chest 1983;83:63-69.
2. Kudoh S, Uetake T, Hagiwara K, Hirayama M, Hus LH, Kimura H, Sugiyama Y: Clinical effect of low-dose long-term erythromycin chemotherapy on diffuse panbronchiolitis. Jpn J Thorac Dis 1987;25:632-642.
3. Kadota J, Sakito O, Kohno S, Sawa H, Mukae H, Oda H, Kawakami K, Fukushima K, Hiratani K, Kara K: Roxithromycin treatment in patients with chronic lower respiratory tract diseases - Its clinical efficacy and effect on cytokine. J Jpn Assoc Infect Dis 1994;68:27-33.
4. Mikasa K, Sawaki M, Kita E, Konishi M, Maeda K, Hamada K, Takeuchi S, Masutani T, Sano R, Kunimatsu M, Kashiba S, Narita N: Long-term chemotherapy using erythromycin (EM) for chronic lower airway infection: Effectiveness of clarithromycin in EM ineffective cases. J Jpn Assoc Infect Dis 1992;66:1097-1104.
5. Ortaldo JR, Winkler-Pickett R, Kopp W, Kawasaki A, Nagashima A, Okumura K, Yagita H, Bach FH: Relationship of large and small CD3-CD56+ lymphocytes mediating NK-as-sociated activities. J Leukoc Biol 1992;52:287-295.
6. Morimoto C, Letvin NL, Boyd AW, Hagan M, Brown HM, Kornacki MM, Schlossman SF: The isolation and characterization of the human helper inducer T cell subset. J Immunol 1985;134:3762-3769.
7. Morimoto C, Rudd CE, Letvin NL, Schlossman SF: A novel epitope of the LFA-1 antigen which can distinguish killer effector and suppressor cells in human CD8 cells. Nature 1987; 330:479-482.
8. Tanaka M, Kawanami O, Satoh M, Yamaguchi K, Okada Y, Yamasawa F: Endoscopie observation of peripheral airway lesion. Chest 1988; 93:228-233.
9. Sato A, Chida K, Iwata M, Hayakawa H: Study of bronchus-associated lymphoid tissue in patients with diffuse panbronchiolitis. Am Rev Respir Dis 1992;146:473-478.
10. Goswami SK, Kivity S, Marom Z: Erythromycin inhibits respiratory glycoconjugate secretion from human airways in vitro. Am Rev Respir Dis 1990;141:72-78.
11. Kadota J, Sakito O, Kohno S, Sawa H, Mukae H, Oda H, Kawakami K, Fukushima K, Hiratani K, Hara K: A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. Am Rev Respir Dis 1993;147:153-159.
12. Nagai H, Shishido H, Yoneda R, Yamaguchi E, Tamura A, Kurashima A: Long-term low-dose administration of erythromycin to patients with diffuse panbronchiolitis. Respiration 1991;58:145-149.
13. Mukae H, Kadota J, Kohno S, Kusano S, Morikawa T, Matsukara S, Hara K: Increase in activated CD8+ cells in bronchoalveolar lavage fluid in patients with diffuse panbronchiolitis. Am J Crit Care Respir Med 1995;152:613-618.
14. Kadota J, Matsubara Y, Ishimatsu Y, Ashida M, Abe K, Shirai R, Iida K, Kawakami K, Taniguchi H, Fujii T, Kaseda M, Kawamoto S, Kohno S: Significance of IL-1ß and IL-1 receptor antagonist (IL-1Ra) in bronchoalveolar lavage fluid (BALF) in patients with diffuse panbronchiolitis (DPB). Clin Exp Immunol 1996; 103:461-466.
15. Sakito O, Kadota J, Kohno S, Abe K, Shirai R, Hara K: Interleukin 1ß, tumor necrosis factor alpha, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: A potential mechanism of macrolide therapy. Respiration 1996;63:42-48.
16. Kawakami K, Kadota J, Iida K, Fujii T, Shirai R, Matsubara Y, Kohno S: Phenotypic characterization of T cells in bronchoalveolar lavage fluid (BALF) and peripheral blood of patients with diffuse panbronchiolitis: The importance of cytotoxic T cells. Clin Exp Immunol 1997; 107:410-416.
17. Mukae H, Ashitani J, Nakazato M, Taniguchi H, Date Y, Ihi T, Shiomi K, Mashimoto H, Kadota J, Kohno S, Hara K, Matsukara S: A study of defensins in bronchoalveolar lavage fluid in patients with diffuse panbronchiolitis. J Jpn Assoc Infect Dis 1995;69:975-981.
18. Thompson AB, Daughton D, Robbins RA, Ghafouri MA, Oehlerking M, Rennard SI: Intraluminal airway inflammation in chronic bronchitis: Characterization and correlation with clinical parameters. Am Rev Respir Dis 1989;140:1527-1537.
19. Kindt GC, Weiland JE, Davis WB, Gadek JE, Dorinsky PM: Bronchiolitis in adults: A reversible cause of airway obstruction associated with airway neutrophils and neutrophil products. Am Rev Respir Dis 1989;140:483-492.
20. Silva LE Jr, Jones JAH, Cole PJ, Poulter LW: The immunological component of the cellular inflammatory infiltrate in bronchiectasis. Thorax 1989;44:668-673.
21. Fournier M, Lebargy F, Ladurie FLR, Lenormand E, Pariente R: Intraepithelial T-lymphocyte subsets in the airways of normal subjects and of patients with chronic bronchitis. Am Rev Respir Dis 1989;140:737-742.
22. Ollerenshaw SL, Woolcock AJ: Characteristics of the inflammation in biopsies from large airways of subjects with chronic airflow limitation. Am Rev Respir Dis 1992;145:922-927.
23. Saetta M, Stefano AD, Maestrelli P, Ferraresso A, Drigo R, Potena A, Ciaccia A, Fabbri LM: Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. Am Rev Respir Dis 1993;147:301-306.
24. Ohno S, Sugiyama Y, Kitamura S: Clinical effects of low-dose and long-term erythromycin in diffuse panbronchiolitis with chronic respiratory failure. Jpn J Thorac Dis 1993;31:1251-1256.